FDA Approves GSK’s Drug Arnuity Ellipta to Treat Asthma in the US
Asthma
The U.S. Food and Drug Administration recently approved GlaxoSmithKline‘s treatment of asthma, Arnuity Ellipta (fluticasone furoate inhalation powder), as a prophylactic therapy in patients aged 12 years and older. Arnuity Ellipta is a once-daily ... Read more